Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial

DSpace Repository

Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial

Author: Ross, S. A.; Caballero, A. E.; Del Prato, S.; Gallwitz, B.; Lewis-D'Agostino, D.; Bailes, Z.; Thiemann, S.; Patel, S.; Woerle, H. -J.; von Eynatten, M.
Tübinger Autor(en):
Gallwitz, Baptist
Published in: Diabetes Obesity & Metabolism (2015), Bd. 17, H. 2, S. 136-144
Verlagsangabe: Wiley - Blackwell
Language: English
Full text: http://dx.doi.org/10.1111/dom.12399
ISSN: 1462-8902
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)